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ABSTRACT: Understanding the mechanism of interaction between pharmaceutical molecules (APIs) and impurities on crystal
surfaces is a key concept in understanding puriﬁcation and for the design of pharmaceutical crystallization processes. Several
techniques may be used to study crystal surface properties, such as scanning electron microscopy (SEM) and X-ray
photoelectron spectroscopy (XPS), which provide detailed imaging and elemental surface characterization. Time of ﬂight
secondary ion mass spectrometry (TOF-SIMS) is valuable in determining molecular identity and distribution. By combining
TOF-SIMS, SEM, and optical (OM) and Raman microscopies, we can evaluate the usefulness of TOF-SIMS as a surface
characterization technique for pharmaceutical crystals. 4-Nitrophenol has been selected as an impurity that can be incorporated
during crystallization of acetaminophen (paracetamol). This study explores the distribution of impurity and its concentration on
the diﬀerent crystal faces of samples obtained by crystallization over a range of impurity loadings and supersaturation conditions.
Raman maps of paracetamol single crystal faces were analyzed using the characteristic Raman peak intensity of 4-nitrophenol to
identify regions where it accumulated; Raman maps of three single crystals produced in the presence of 4-nitrophenol using
diﬀerent crystallization procedures highlight how it can be diﬃcult to detect very low concentrations of similar chemical species.
In contrast, the 4-nitrophenol monoisotopic mass obtained via TOF-SIMS was shown to be detectable in all the three single
crystals produced. This indicates that TOF-SIMS can be a valuable technique for single crystal impurity distribution mapping
even when the impurity concentration is very low.
■ INTRODUCTION
Active pharmaceutical ingredients (API) are typically produced
by chemical synthesis. Various components, including residual
solvents and trace amounts of inorganic and organic
compounds including unreacted starting materials and by-
products, are typically present at the end of the synthesis and
are removed to a large extent by crystallization. All of these
substances that remain in the ﬁnal API product are deﬁned as
impurities. Impurities related to the synthesis can be classiﬁed
as intermediate, penultimate intermediate, and byproducts that
are produced during the diﬀerent synthesis steps, all of which
have chemical structures that are, to some degree, similar to the
API, as are any degradation products.1
Structurally related substances can change API crystallization
behavior. When the solubility of these substances is similar to
or less than the API solubility, elimination of these substances
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may be diﬃcult. Furthermore, these impurity molecules have
the capability to modify API solubility, nucleation, and crystal
growth resulting in changes in crystal morphology and
crystallization kinetics.
Paracetamol, also known as acetaminophen, is a molecular
organic compound and an API that shows analgesic and
antipyretic eﬀects.2 Paracetamol consists of a benzene ring core,
substituted by one hydroxyl group and a methylamide group in
the para position.3,4 The amide and hydroxyl groups act as
hydrogen bond donors, whereas the carbonyl and hydroxyl
groups act as acceptors. Paracetamol has three diﬀerent
polymorphic forms: form I, the stable form, crystallizes in a
monoclinic structure; metastable form II adopts an ortho-
rhombic structure; and form III is the most metastable form.5−8
The habit of paracetamol form I crystals can vary from being
plate-like to needle-like depending on the crystallization
conditions. The calculated principal facets of paracetamol
(BFDH modeling) and paracetamol functional groups exposed
on each facet are evaluated in the Supporting Information.9,10
Hendriksen and Grant11 showed that some substances, which
are structurally related to paracetamol, such as acetanilide and
metacetamol inhibit the primary nucleation of paracetamol in
aqueous solution. They also suggested that the nucleation rate
is modiﬁed through a mechanism similar to that previously
reported for crystal growth modiﬁcation by structurally related
additives. Hendriksen et al.10 and then Kuvadia and Doherty12
have proposed that structurally related additives may inﬂuence
the nucleation and growth of crystals in three principal ways:
• Blocking adsorption of solute molecules onto the crystal
surface and therefore inducing morphological
changes;10,13 for example, 4-acetoxyacetanilide acts as a
blocking impurity inhibiting crystal growth on the (110)
facet.
• Docking onto the surface and become incorporated into
the crystal lattice without signiﬁcantly aﬀecting the arrival
of further API molecules;10 metacetamol operates in this
way.
• Disrupting the emerging nucleus to inhibit the nucleation
process;10 metacetamol is also described as a disrupting
impurity.
Various experimental methodologies to evaluate the role of
structurally related impurities on crystal surface texture and
crystal morphology are reported in the literature.10,13−17
Optical (OM) and scanning electron microscopy (SEM) are
useful to investigate crystal morphology, aspect ratio, and, to
provide some information about surface texture. Saleemi17
reported the inﬂuence of metacetamol on paracetamol crystal
morphology, whereby the habit was altered from a tabular to
columnar with increasing metacetamol content during crystal-
lization. The authors also analyzed the variation of induction
time, crystal size distribution (PSD), and solution concen-
tration during paracetamol crystallization; these were enabled
by the use of in situ UV spectroscopy and focused beam
reﬂectance measurements (FBRM)
Prasad et al.16 and Chow et al.15 examined the role of 4-
acetoxyacetanilide solution concentrations and supersaturation
levels on the transition of paracetamol crystals from columnar
to plate-like habits. In addition to this they were able, using
scanning and optical microscopy, to investigate shape and
strain/defect content, as well as quantiﬁcation of 4-
acetoxyacetanilide incorporation into paracetamol crystals.
Optical and electron microscopy and atomic force
microscopy (AFM) allow surface roughness and crystal growth
mechanism to be explored. For example, Thompson et al.13
investigated how the morphology and chemical properties of
the (001) face of paracetamol can be aﬀected by the presence
of diﬀerent structurally related impurities.
One of the challenges faced in previous investigations was
extracting information about both the chemical and topo-
graphic character of individual crystal faces using a single
technique. In this work, we have explored alternative analytical
tools such as Raman mapping and time of ﬂight secondary ion
mass spectrometry (TOF-SIMS) in order to evaluate their
eﬀectiveness and sensitivity when used to simultaneously detect
impurity distribution on the crystal surface and surface
modiﬁcation caused by the structurally related impurities.
TOF-SIMS is a surface-sensitive analytical technique that is
extensively used in material science18−22 and has begun to be
applied in pharmaceutical applications in recent years.23−28 The
technique utilizes a pulsed ion beam to release molecules from
the outermost layers of a sample surface resulting in the
emission of both neutral and charged species (atoms and
molecules); the charged species are termed secondary ions.29,30
These ions, in turn, are extracted into a time-of-ﬂight mass
analyzer for detection and quantiﬁcation. Moving the ion beam
Table 1. Crystallization Procedure for Single Crystals Prepared in This Work
crystallization method preparation single crystals obtained
cooling crystallizations raw material: supersaturated solution of paracetamol with 4 mol % of 4-
nitrophenol
pure paracetamol (PP)
temperature proﬁle: dissolution = 50 °C pure 4-nitrophenol (PN)
cooling = 50 °C down to 5 °C paracetamol crystal with the presence of 4 mol % 4-
nitrophenol (P4%N)
isolation = 5 °C
crystal with drop of 4-
nitrophenol
raw material: paracetamol single crystal grown by the method above, 4-
nitrophenol solution (1500 mg/g ethanol)
layer of 4-nitrophenol crystals deposited on the surface of
the paracetamol crystal surface (PDN)
procedure: dropping 4-nitrophenol solution on a ﬂat dominant surface of
PP and allowing the solvent to evaporate
crystal with 4-
nitrophenol deposit
grown epitaxially
raw material: paracetamol single crystal grown by the method above,
saturated solution of 4-nitrophenol in hexane
very ﬁne needle-like 4-nitrophenol crystals were crystallized
on the surface of paracetamol crystal and in the solution
(PEN)temperature proﬁle: immersion = room temperature
cooling = room temperature down to 5 °C
isolation = room temperature
procedure: immersing the PP crystal in the saturated solution of 4-
nitrophenol and allowing 4-nitrophenol crystals to grow on the
paracetamol crystal surface
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across the sample surface enables elemental and molecular
surveying of the sample surface.
This study focuses on the API paracetamol and 4-
nitrophenol as a paracetamol related impurity. 4-Nitrophenol
was chosen as the representative impurity as it is a precursor in
the synthesis of paracetamol and hence could be present as an
impurity during the crystallization process. We investigate the
limit of detection for this impurity on crystal surfaces by
preparing samples using three diﬀerent crystallization techni-
ques: cooling crystallization; surface deposition via solvent drop
evaporation; and epitaxial growth. The solubility of both
compounds in the diﬀerent solvents (ethanol and hexane) was
investigated to control the supersaturation through prediction
methods using COSMOTherm and by experimental measure-
ment by isothermal equilibration.
Optical microscopy (OM) and scanning electron microscopy
(SEM) were used in combination to evaluate crystal
morphology, surface character, and aspect ratio. AFM was
used to study crystal surface topography; the solid state and
chemical composition were determined by single crystal X-ray
diﬀraction (SC-XRD) and HPLC, respectively.
■ EXPERIMENTAL SECTION
Materials. Paracetamol (4-actamidophenol, Bioxtra, ≥99%), 4-
nitrophenol (≥99%), absolute ethanol (GC grade ≥99.8%), and n-
hexane (≥95%) were all purchased by Sigma-Aldrich. 4-Nitrophenol is
an intermediate in the synthesis of paracetamol;2 if present at the end
of the synthesis, it could aﬀect the crystallization process, and if not
rejected during the crystallization, it could be incorporated into the
crystal lattice. 4-Nitrophenol shows oral, respiratory, and skin toxicity.
4-Nitrophenol shows speciﬁc target organ toxicity for repeated
exposure. n-Hexane and ethanol are ﬂammable solvents. n-Hexane
shows oral, respiratory, and skin toxicity. n-Hexane is suspect of
carcinogenic eﬀects.
Methods. To test the sensitivity limit for impurity detection on
crystal faces, three diﬀerent crystallization methods were implemented
(Table 1).
Cooling Crystallization from Impure Solution. A single crystal
of paracetamol containing 4-nitrophenol as an impurity was obtained
by preparing a supersaturated solution of paracetamol (0.88 g) in
absolute ethanol (5 g) by the addition of 4% mol of 4-nitrophenol
(0.029 g). The solution was heated to 50 °C and allowed to cool to
room temperature and then further to 5 °C in a refrigerator. A suitable
single crystal of paracetamol with 4-nitrophenol (P4%N) of size
exceeding 1 mm was then isolated from the solution.
Paracetamol Crystal with 4-Nitrophenol Deposited by
Evaporation. Paracetamol single crystals with a surface deposit of
4-nitrophenol (PDN) were prepared by growing pure paracetamol
single crystals (PP) using the same cooling crystallization procedure
outlined above but in the absence of the impurity. After the pure
crystals were isolated and dried at room temperature, a room
temperature saturated solution of 4-nitrophenol in ethanol was
prepared (1500 mg/g ethanol). A drop of this solution was dispensed
onto the dominant face of the PP crystal using a microsyringe. The
solvent was allowed to evaporate at ambient temperature producing a
layer of 4-nitrophenol crystals on the paracetamol crystal surface.
Crystal with 4-Nitrophenol Epitaxially Deposited. Epitaxial
deposition of 4-nitrophenol (PEN) onto the surface of a paracetamol
crystal was achieved by growing a pure paracetamol single crystal (PP)
using the procedure described earlier followed by immersion in a
saturated solution of 4-nitrophenol in hexane at room temperature
(the composition was in accordance with solubility data reported in
the Supporting Information). The crystal and solution was then cooled
to 5 °C. Hexane was selected as solvent for the 4-nitrophenol solution
due to the relatively high solubility of paracetamol in ethanol, which
may have caused slight dissolution of the single crystal during the
preparation of the earlier sample. Given the much larger quantity of
solvent to be used in this preparation, it was considered prudent to use
an alternative solvent. Very ﬁne needle-like 4-nitrophenol crystals were
formed on the surface of paracetamol crystal and in the surrounding
solution.
To provide a comparator to allow chemical and physical changes to
be identiﬁed, pure crystals of paracetamol and 4-nitrophenol were
prepared from an ethanol solution using the method described earlier.
Solubility Experiments. The solubility of paracetamol in ethanol
was taken from the literature;31 its solubility and that of 4-nitrophenol
in ethanol and hexane were compared with predictions made using
COSMOTherm and with experimental measurements made by
isothermal equilibration. Preweighed suspensions of paracetamol and
4-nitrophenol in ethanol and hexane were prepared and placed in an
incubator (Incubator S160D, Stuart) on a multiposition stirrer plate
and held isothermally at the selected equilibration temperatures of 25,
40, and 55 °C, and equilibrated with agitation for 24 h. Once the 24 h
equilibration period was competed, 1 mL samples were taken and the
mass recorded. The samples were then left without lids in a fume hood
for 24 h to allow the solvent to evaporate. After 24 h, the sample vials
were weighed and their mass recorded. Finally, the sample vials were
placed in a vacuum oven (Gallenamp) for 24 h at room temperature
and (20 mbar) prior to recording the ﬁnal dry residue mass, which was
used to calculate the solubility of each compound.
Solid State and Composition Analysis. The chemical
composition of single crystal samples of paracetamol with nitrophenol
were analyzed using an Agilent 1290 UPLC, 6530 Q-TOF using an
internal standard method. An Agilent Poroshell 120 EC-C18 (3.0 × 50
mm, 2.7 μm) column was used. The analysis was performed at 25 °C,
using a 1.5 mL/min ﬂow rate recording the absorbance at 230 nm.
The mobile phase was 20:80 methanol/water. The samples were
prepared by dissolving the selected crystals in 100 mL of a 5% w/w
methanol/water solution. A calibration curve for the 4-nitrophenol
impurity was prepared using 5 μL solutions containing 0.14 mg/mL
paracetamol spiked with 5−15% (w/w) of 4-nitrophenol. Samples
were analyzed in triplicate. Chemical composition analysis is a
destructive analysis that was performed as last analytical technique.
X-ray diﬀraction intensities were collected on a Bruker APEX 2
diﬀractometer coupled with an Incoatec IuS Mo microsource (0.71073
Å) operating at room temperature (293 K). A total of 780 frames was
collected using three angular settings with a scan width of 0.5° in
omega. Two crystals from each crystallization experiment were face-
indexed to assign the Miller indices.
Chemical Character and Surface Texture Evaluation. A
stereomicroscope (Brunel Microscopes Ltd., BMDZ zoom stereo-
microscope) was used to evaluate single crystal morphology and
identify the main macroscopic features. A Leica DM6000M micro-
scope was used in diﬀerential interference contrast (DIC) mode to
analyze the surface texture of the crystals. A Hitachi TM-1000 version
02−11 scanning electron microscope was used to evaluate the
microsurface texture and features of the crystals. The operating
conditions for the SEM experiments were back scattered detector,
accelerating voltage 15000 V, magniﬁcation 200×, working distance
6700 μm, emission current 57.4 mA, scan speed slow, and vacuum
conditions 15.0 kV.
Raman microscopy in mapping mode and TOF-SIMS were used to
investigate the distribution of impurities on the crystal faces.
Raman microscopy may be operated in mapping mode to analyze
localized regions of samples by vibrational microspectroscopy.32−34
Mapping involves the sequential measurement of the Raman spectra of
adjacent regions of a sample by moving each region of the surface of
the sample into the focal point of a Raman microscope. A Horiba
Raman Xplora microscope was used to perform the Raman mapping.
A 532 nm laser source coupled with a 50× objective (1.23 μm spatial
beam width), 50 μm of slit, and 100 μm aperture was used to collect
the Raman spectra over the range 50 to 3500 cm−1 at room
temperature. Data acquisition time was 2 s with averaging over two
spectra with a delay of 2 s. A 25% ﬁlter was used to reduce the eﬀects
of interaction of the laser with the sample. The characteristic Raman
peaks for paracetamol and 4-nitrophenol were evaluated from
published sources35,36 coupled with our own measurements of the
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individual Raman spectra of paracetamol (PP) and 4-nitrophenol
(PN) crystals. The main 4-nitrophenol Raman peak has a characteristic
frequency of 1111 cm−1, which is related to −CN stretching of the
nitro group.36 Based on this characteristic peak, 2D maps were created
for 20 × 20 μm or 10 × 10 μm sampling areas by calculation of the
intensity ratio between peak and baseline intensity; this was performed
using Origin software. Measurements were conducted on crystals
obtained from the three diﬀerent crystallization conditions.
The TOF-SIMS instrument used in this study was a TOF-SIMS 5
from IONTOF, which has four diﬀerent operational modes; surface
spectroscopy, surface imaging, depth proﬁling, and 3D-imaging. Depth
proﬁling approach is a destructive analysis. Of these modes, surface
spectroscopy and surface imaging were the main approaches used.
Data were collected in both positive and negative polarity for all the
samples that were prepared. Negative polarity was selected as the
preferred mode due to enhanced molecular polarizability of the 4-
nitrophenol fragments. All images were collected using the Bi3
+2 ion
source with settings adjusted toward high lateral resolution (30 keV
base setting, due to double charge eﬀective 60 keV, 100 ns pulse width,
0.05 nA beam current). All crystals were analyzed, in each case, as a
sample area of 100 × 100 μm. While the PP and PN crystals were
recorded at 256 × 256 px raster size, P4%N was recorded at 1024 ×
1024 px raster size. The total dose densities recorded were 4 × 1011
ions/cm2 for the PP and PN crystals and 9 × 1011 ions/cm2 for the
P4N crystal. To aid the assignment of all mass fragments, the software
tools NIST 08 MS Demo and AMDIS 2.6 were used.
Atomic force microscopy (AFM) was carried out using a Bruker
AFM with Icon Scanner system and Scan Asyst in air experiment
mode, equipped with a MPP-12120-10 tip. The dimensions of the scan
area were 50 × 50 μm for each of the samples studied.
■ RESULTS AND DISCUSSION
Chemical Character and Surface Texture Evaluation.
The SC-XRD, OM, SEM, and AFM results are reported in the
Supporting Information. The SC-XRD of the pure crystals were
concordant with the literature values for form I (monoclinic) of
paracetamol8,37,38 and the alpha form of 4-nitrophenol.3 The
lattice parameters of P4%N suggest that 4-nitrophenol modiﬁes
the paracetamol crystal lattice without causing a polymorphic
change; however, it is known that the errors calculated from X-
ray data are overoptimistic given the area-detector and the
systematic errors in data collection.39,40 Observation reveals a
new crystal face and changes in face shapes on the paracetamol
crystal grown in the presence of 4-nitrophenol compared with
the crystals grown from pure solution. The change in
morphology associated with the incorporation of 4-nitrophenol
in the paracetamol lattice is presumed to be due to the reduced
capability of the nitro group to form hydrogen bonds compared
with the amide. This indicates that the 4-nitrophenol, though
present in small quantities, acted as a crystal face modiﬁer.
Figure 1. Raman spectra of paracetamol (PP) (top) and 4-nitrophenol (PN) (bottom).
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OM in DIC mode, SEM images, and AFM images were
examined to assess surface texture characteristics of pure
paracetamol (PP), pure 4-nitrophenol (PN), and the three
diﬀerent impure crystals P4%N, PDN, and PEN (the images
are available in the Supporting Information). Comparing pure
paracetamol and pure 4-nitrophenol single crystals surface
texture diﬀerences and diﬀerent edge shapes were observed: PP
crystal shows characteristic edge steps, while rounded and
shorter steps are visible on the PN crystal. Examination of the
OM and SEM images indicates that 4-nitrophenol added as
impurity during growth acted as a texture modiﬁer, increasing
the number of steps and other surface defects; this is consistent
with the observation of Prasad and Thompson.13,16 PDN
crystal were examined within the perimeter area of the
evaporated 4-nitrophenol saturated drop. Needle-like crystals
of 4-nitrophenol were randomly distributed in the core area of
the drop, while at the perimeter they were aligned in the
direction of spread. Areas not covered by the spreading drops
of 4-nitrophenol solution showed characteristic paracetamol
surface texture. The 4-nitrophenol crystals grown on the
paracetamol crystal surface by rapid solvent evaporation exhibit
a needle-like morphology that is quite diﬀerent from the slowly
grown 4-nitrophenol crystal for SCXRD. This may be due to
rapid growth by evaporation or, alternatively, could be due to
the formation of the beta polymorph of 4-nitrophenol,41 which
have a needle-like morphology (the 4-nitrophenol crystals were
too small to determine their crystal form). The epitaxially
grown crystals including both micrometer and nanometer size
crystals of 4-nitrophenol on the paracetamol crystal surface are
seen in the OM image. These crystals showed the same needle-
like shape observed when 4-nitrophenol was deposited by
evaporation of a drop of ethanol saturated solution.
Raman and TOF-SIMS Analysis. Raman microscopy in
mapping mode and TOF-SIMS were evaluated as comple-
mentary techniques, both have the potential to allow the
distribution of 4-nitrophenol on the crystal surface to be
determined. As described previously three diﬀerent crystal-
lization techniques were used to prepare samples containing
both paracetamol and 4-nitrophenol with which to evaluate the
sensitivity of these two analytical tools to investigate
concentration and distribution. Raman spectra of the pure PP
and PN crystals were collected to establish the diﬀerences in
the spectra between the two compounds to identify character-
istic Raman bonds so that the local composition could be
mapped.
Anitha and co-workers42,43 reported the assignment of
spectral bands for paracetamol, while Vijayalakshmi et al.36
reported the assignment of the Raman bands for 4-nitrophenol.
Characteristic 4-nitrophenol Raman peaks were 303, 869, 1110,
1586, and 3085 cm−1. Due to the absence of overlapping
features in the spectral region, the CN stretching peak at 1111
cm−1 was selected for evaluating the presence of 4-nitrophenol
on the paracetamol crystal surface (Figure 1). The Raman maps
presented in Figures 2−4 were obtained by tracking this
characteristic peak of 4-nitrophenol with respect to the
diﬀerence between the maximum peak intensity and baseline
intensity. By processing the spectra in this way, concentration
contour maps were generated.
Regions of the crystal surfaces were selected to maximize the
probability of detecting the 4-nitrophenol. In the case of the
crystal grown from paracetamol solution containing 4 mol % 4-
nitrophenol, P4%N, the Raman map was constructed across a
growth step (Figure 2), while in the case of the crystal with 4-
nitrophenol solution deposited by evaporation, PDN, the
detection area was localized on the perimeter area of the drop
(Figure 3). In the case of the epitaxially deposited 4-
nitrophenol, PEN, the map centered on an area rich in
needle-like 4-nitrophenol crystals (Figure 4). Comparing
Raman maps of P4%N, PDN, and PEN crystals, only the
PEN crystal showed a signiﬁcant diﬀerence between peak and
baseline intensity, and in some areas, the peak intensity to
baseline intensity ratio at the selected characteristic wavelength
exceeded 10. This indicates that, under favorable conditions,
Raman microscopy may be used in mapping mode to evaluate
the distribution of chemical species.
The TOF-SIMS mass spectra and maps of the three diﬀerent
crystals were obtained in a similar way to the Raman maps. The
pure PP and PN crystals were analyzed to obtain mass spectra
of these two pure crystals in order to identify the characteristic
mass fragments ion.
To verify the mass spectra obtained and to conﬁrm the
fragmentation ion identities, two software tools were used;
Figure 2. Raman map of P4%N crystal. Crystal was analyzed in a step
area. Area of detection 20 × 20 μm. Black dots on the map correspond
to the position of the laser detection. Scale is related to the intensity of
the 4-nitrophenol peak with respect to the baseline.
Figure 3. Raman map of PDN crystal. The surface feature of the
crystal analyzed in the perimeter area where a drop of 4-nitrophenol
solution had evaporated. Area of detection 10 × 10 μm. The black dots
on the map correspond to the position of the laser detection. Scale is
related to the intensity of the 4-nitrophenol peak with respect to the
baseline.
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NIST 08 MS Demo and AMDIS 2.6 from NIST. The 10 largest
molecular fragment peaks from paracetamol and 4-nitrophenol
are listed and their mass ion identiﬁed in the Supporting
Information.
The distinctive molecular fragments for 4-nitrophenol were
38, 63, 65, and 139 m/z. Analyzing fragment mass images at
139 m/z, which corresponds to the 4-nitrophenol mono-
isotopic mass, allowed the distribution of 4-nitrophenol to be
determined.
TOF-SIMS mass fragment images for the P4%N crystal
suggest a homogeneous distribution of 4-nitrophenol (138 m/
z) across the crystal surface. The step surface texture of the
crystal can be seen in Figure 5, which is consistent with SEM
and OM images also obtained (see Supporting Information).
TOF-SIMS mass fragment images of the PDN crystal (Figure
6) allow the evaporated 4-nitrophenol solution drop on top of
the paracetamol crystal to be investigated. The images show a
layer of 4-nitrophenol (138 m/z) covering a large area of the
crystal with only small areas of paracetamol (150 m/z) still
remaining exposed.
From these images, it appears that the 4-nitrophenol drop
spread across the surface leaving a covering layer of 4-
nitrophenol behind, the image does not, however, reveal the
shape of the individual impurity crystals.
Figure 7 shows the TOF-SIMS mass ion fragment images of
the PEN crystal. A needle-shaped 4-nitrophenol crystal is
clearly seen at 138 m/z. The corresponding image for the
molecular ion fragment of paracetamol (150 m/z) shows the
uniform spread of paracetamol; the area covered by the 4-
nitrophenol appears darker as the surface of the paracetamol
crystal is not accessed by the ionization beam. This sequence of
ﬁgures (Figures 5−7) demonstrates the capability of TOF-
SIMS to evaluate the distribution of diﬀerent chemical species
on crystal surfaces.
■ CONCLUSIONS
Three diﬀerent approaches, epitaxy, droplet evaporation, and
cooling crystallization were used to create paracetamol crystals
with molecules of 4-nitrophenol present on the crystal surface
in order to study eﬀectiveness of diﬀerent analytical techniques
to investigate the quantity and spatial distribution of the
impurity on crystal surface and to identify any associated
morphological and surface texture changes.
TOF-SIMS is a relatively new technique for pharmaceutical
material characterization and allows the presence of 4-
nitrophenol to be veriﬁed by the distribution of the
secondary-ion fragments.
The presence and spatial distribution of 4-nitrophenol
crystals generated epitaxially are observed.
In the future, TOF-SIMS can be used to build 3D images
showing the spatial distribution of speciﬁc molecular species
deposited during crystal growth.
SEM, AFM, Raman microscopy, and TOF-SIMS were
evaluated to assess the level at which the impurity 4-
nitrophenol can be detected.
Raman microscopy mapping reveals the impurity location
when the main peak intensity ratio is more intense than the
baseline; for example, the intensity diﬀerence in Figure 4 is
substantially greater than in Figures 2 and 3.
OM, SEM, and AFM show crystal epitaxial growth on pure
paracetamol crystal surface. They reveal surface texture changes
and allow the distribution of small crystal agglomerates to be
observed. These techniques can be used as complementary
analytical tools to address changes in surface texture due to the
presence of impurity in the crystal lattice and on the crystal
surface.
This work demonstrates that TOF-SIMS analysis allowed
investigation of both chemical and topographic character of
Figure 4. Raman map of PEN crystal. The area of the crystal analyzed
was in an area where 4-nitrophenol needle-like crystals were
concentrated. Area of detection 10 × 10 μm. The black dots on the
map correspond to the centers of the spectrum collections. Scale is
related to the intensity of the 4-nitrophenol peak with respect to the
baseline.
Figure 5. Paracetamol with 4% (mol/mol) of 4-nitrophenol. From left to right, 4-nitrophenol molecular ion image at 138 m/z (maximum counts =
16), paracetamol molecular ion image at 150 m/z (maximum counts = 83), and RGB overlay of paracetamol (red) with 4-nitrophenol (green).
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crystal faces and, in combination with other complementary
techniques, proves to be a valuable addition to the analysis of
crystals and their impurities.
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